International Waldenstrom's Macroglobulinemia Foundation (IWMF)
Latest Content
The FDA approval of Brukinsa represents another treatment option with fewer side effects in patients with Waldenstrom's macroglobulinema, however it will not serve as a replacement for other therapies.
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
4
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
5